相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Choline Kinase Active Site Provides Features for Designing Versatile Inhibitors
L. Serran-Aguilera et al.
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2015)
New more polar symmetrical bipyridinic compounds: new strategy for the inhibition of choline kinase α1
Francisco Fermin Castro-Navas et al.
FUTURE MEDICINAL CHEMISTRY (2015)
Targeting cancer with kinase inhibitors
Stefan Gross et al.
JOURNAL OF CLINICAL INVESTIGATION (2015)
Pharmacophore-Based Virtual Screening to Discover New Active Compounds for Human Choline Kinase α1
Lucia Serran-Aguilera et al.
MOLECULAR INFORMATICS (2015)
Dysregulated choline metabolism in T-cell lymphoma: role of choline kinase-α and therapeutic targeting
J. Xiong et al.
BLOOD CANCER JOURNAL (2015)
Preclinical Characterization of RSM-932A, a Novel Anticancer Drug Targeting the Human Choline Kinase Alpha, an Enzyme Involved in Increased Lipid Metabolism of Cancer Cells
Juan Carlos Lacal et al.
MOLECULAR CANCER THERAPEUTICS (2015)
Choline kinase-alpha by regulating cell aggressiveness and drug sensitivity is a potential druggable target for ovarian cancer
A. Granata et al.
BRITISH JOURNAL OF CANCER (2014)
Discovery of a New Binding Site on Human Choline Kinase α1: Design, Synthesis, Crystallographic Studies, and Biological Evaluation of Asymmetrical Bispyridinium Derivatives
Belen Rubio-Ruiz et al.
JOURNAL OF MEDICINAL CHEMISTRY (2014)
The Mechanism of Allosteric Coupling in Choline Kinase1 Revealed by the Action of a Rationally Designed Inhibitor
Maria Sahun-Roncero et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2013)
TR-644 a novel potent tubulin binding agent induces impairment of endothelial cells function and inhibits angiogenesis
Elena Porcu et al.
ANGIOGENESIS (2013)
New non-symmetrical choline kinase inhibitors
Santiago Schiaffino-Ortega et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2013)
Determination of Potential Scaffolds for Human Choline Kinase 1 by Chemical Deconvolution Studies
Maria Sahun-Roncero et al.
CHEMBIOCHEM (2013)
Concise Synthesis and Biological Evaluation of 2-Aroyl-5-Amino Benzo[b]thiophene Derivatives As a Novel Class of Potent Antimitotic Agents
Romeo Romagnoli et al.
JOURNAL OF MEDICINAL CHEMISTRY (2013)
Design of symmetrical and nonsymmetrical N,N-dimethylaminopyridine derivatives as highly potent choline kinase alpha inhibitors
Sebastian Trousil et al.
MEDCHEMCOMM (2013)
The mutational landscape of phosphorylation signaling in cancer
Jueri Reimand et al.
SCIENTIFIC REPORTS (2013)
Novel 4-Amino Bis-pyridinium and Bis-quinolinium Derivatives as Choline Kinase Inhibitors with Antiproliferative Activity against the Human Breast Cancer SKBR-3 Cell Line
Veronica Gomez-Perez et al.
CHEMMEDCHEM (2012)
Design, synthesis, theoretical calculations and biological evaluation of new non-symmetrical choline kinase inhibitors
Belen Rubio-Ruiz et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2012)
Balance of human choline kinase isoforms is critical for cell cycle regulation Implications for the development of choline kinase-targeted cancer therapy
Jens Gruber et al.
FEBS JOURNAL (2012)
Protein kinase signaling networks in cancer
John Brognard et al.
CURRENT OPINION IN GENETICS & DEVELOPMENT (2011)
Surflex-Dock 2.1: Robust performance from ligand energetic modeling, ring flexibility, and knowledge-based search
Ajay N. Jain
JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN (2007)
Binuclear titanocenes linked by the bridge combination of rigid and flexible segment: Synthesis and their use as catalysts for ethylene polymerization
Xiaohui Xiao et al.
JOURNAL OF MOLECULAR CATALYSIS A-CHEMICAL (2007)
Opinion - Why is cancer drug discovery so difficult?
Alexander Kamb et al.
NATURE REVIEWS DRUG DISCOVERY (2007)
Elucidation of human choline kinase crystal structures in complex with the products ADP or phosphocholine
Enrico Malito et al.
JOURNAL OF MOLECULAR BIOLOGY (2006)
Noninvasive magnetic resonance spectroscopic pharmacodynamic markers of the choline kinase inhibitor MN58b in human carcinoma models
NMS Al-Saffar et al.
CANCER RESEARCH (2006)
Symmetrical bis-quinolinium compounds:: New human choline kinase inhibitors with antiproliferative activity against the HT-29 cell line
R Sánchez-Martín et al.
JOURNAL OF MEDICINAL CHEMISTRY (2005)
Chemical approaches to the discovery and development of cancer therapies
S Neidle et al.
NATURE REVIEWS CANCER (2005)
Structure and function of choline kinase isoforms in mammalian cells
C Aoyama et al.
PROGRESS IN LIPID RESEARCH (2004)
From Ras signalling to ChoK inhibitors:: a further advance in anticancer drug design
AR de Molina et al.
CANCER LETTERS (2004)
Choline kinase activation is a critical requirement for the proliferation of primary human mammary epithelial cells and breast tumor progression
A Ramírez de Molina et al.
CANCER RESEARCH (2004)
Controlled microwave heating in modern organic synthesis
CO Kappe
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2004)
Inhibition of choline kinase as a specific cytotoxic strategy in oncogene-transformed cells
A Rodríguez-González et al.
ONCOGENE (2003)
Conformational dynamics of a bispyridinium cyclophane
A Conejo-García et al.
JOURNAL OF ORGANIC CHEMISTRY (2003)
Bispyridinium cyclophanes:: Novel templates for human choline kinase inhibitors
A Conejo-García et al.
JOURNAL OF MEDICINAL CHEMISTRY (2003)
The crystal structure of choline kinase reveals a eukaryotic protein kinase fold
D Peisach et al.
STRUCTURE (2003)
Overexpression of choline kinase is a frequent feature in human tumor-derived cell lines and in lung, prostate, and colorectal human cancers
A Ramírez de Molina et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2002)
Quantitative structure-activity relationships for a series of symmetrical bisquaternary anticancer compounds
JM Campos et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2002)
分享论文
